Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study

Fig. 1

Full trial protocol and flow diagram. A 146 patients were initially enrolled. 14 patients were admitted for other reason than acute respiratory failure (10 post-surgical, 2 myocardial infarctions, 1 ischemic stroke, 1 intracranial haemorrhage). Therefore, 132 patients were included in the analyses, whereof 75 received antifungal prophylaxis and 57 did not receive antifungal prophylaxis. B Inclusion and exclusion criteria of the study. COVID-19 coronavirus disease 19; SARS-CoV-2 severe acute respiratory syndrome corona virus 2; PCR polymerase chain reaction; ICU intensive care unit

Back to article page